Report

  1. Home
  2. Discounted reports

Neurointerventional Devices Market By Product (Stents, Embolic Coils, Catheter, Wires, Others), By Indication (Brain Aneurysm, Stroke, Others), By Application (Hospitals, Ambulatory Surgical Centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Market Report I 2023-06-01 I 282 Pages I Allied Market Research
Discounted by 10% to 2024-11-15

The global neurointerventional devices market was valued at $2.6 billion in 2022, and is projected to reach $5.3 billion by 2032, growing at a CAGR of 7.5% from 2023 to 2032.The neurointerventional devices are medical devices used in the field of neurointerventional radiology. neurointerventional radiology, also known as neurointerventional surgery or endovascular neurosurgery, is a medical specialty that focuses on treating various neurological conditions through minimally invasive procedures. Neurointerventional devices are specialized tools designed to access the blood vessels of the brain and spinal cord to diagnose and treat a wide range of neurological disorders. These devices are used by neurointerventional radiologists and neurosurgeons to perform procedures such as cerebral angiography, embolization, thrombectomy, and stenting.
The neurointerventional devices market is driven by increase in prevalence of neurological and disorders, rise in preference towards minimally invasive procedures, and rise in awareness of neurological disorders among general population. Neurological disorders are on the rise globally. These devices play a crucial role in the treatment of conditions such as ischemic and hemorrhagic stroke, cerebral aneurysms, arteriovenous malformations, and other vascular and non-vascular neurological disorders. According to World Stroke Organization, the stroke reached epidemic proportions in 2023. Globally 25% of adults over the age of 25 are expected to have a stroke in their lifetime and over 110 million people in the world have already experienced stroke. Epidemic proportions refers to an increase in the number of cases of a disease above what is normally expected in that population in that area.According to the World Stroke Organization, around 12.2 million people were predicted to have their first stroke in the year 2023, globally. Furthermore, according to a 2023 study by National Library of Medicines, around 3.2% of population is affected by cerebral aneurysms, globally.
Neurointerventional devices play a crucial role in the diagnosis and treatment of neurovascular conditions. For example, catheters and imaging systems are used during cerebral angiography to visualize blood vessels and detect abnormalities. Embolic coils and flow diverters help to treat aneurysms by promoting clotting or redirecting blood flow. Thus, rise in incidence of neurological disorders surge the demand for neurointerventional procedures and devices and propel the growth of the market.Furthermore, increase in preference towards minimally invasive procedures is shaping the growth of the neurointerventional devices market. Minimally invasive procedures have revolutionized the field of neurointerventional by offering several advantages over traditional open surgeries such as reduced invasiveness, shorter hospital stays, faster recovery, improved precision and outcomes, and lower risk of complications. Due to the advantage such as lower risk and faster recovery, there has been a spike in patient preference towards the minimally invasive procedures.
A study performed by the National Library of Medicine, in 2020, reported that the preference of patients toward minimally invasive treatments raised by 36% over the last 16 years. Minimally invasive procedures involve accessing the affected area through small incisions, often guided by imaging techniques such as fluoroscopy or angiography. Neurointerventional devices enable physicians to navigate complex blood vessels and deliver treatments precisely. Catheters, guidewires, and balloons are used in thrombectomy procedure in patient diagnosed with stroke, which helps to remove the blood clots in brain.
In addition, stents and flow diverters are also used to help restore blood flow in blocked or weakened vessels. Thus, the minimally invasive procedures have emerged as more efficient in terms of faster recovery of patient, lower risk management, and improved precision and outcomes, as compared to the traditional surgical methods, leading to high adoption of minimally invasive procedures by patients and healthcare professionals, resulting in the growth of the neurointerventional devices market.
In addition, rise in awareness of neurological disorders has emerged as a significant driver for the neurointerventional devices market. Neurological disorders encompass a range of conditions affecting the brain, spinal cord, and peripheral nervous system. Over recent years, rise in incidence of neurological disorders, advancements in diagnostic techniques, media coverage and advocacy efforts to spread awareness about the neurological disorders, and government initiatives towards treatment support of neurological disorders have led to increase in public awareness of these disorders.
For instance, The National Policy for Rare Diseases scheme, by government of India, has provision for financial support of up to Rs. 50 lakhs to the patients suffering from any category of the rare diseases and for treatment in the Centre of Excellence (CoE) mentioned in NPRD-2021. Moreover, rise in sedentary lifestyles, unhealthy diets, environmental factors, and aging population, further lead to various neurological disorder and boost the growth of the market. Conditions such as stroke, cerebral aneurysms, and arteriovenous malformations can have severe consequences if not diagnosed and treated promptly. Thus, the need for neurointerventional procedure increase the demand for neurointerventional device and propel the growth of the market. However, the high cost of neurointerventional devices is expected to restrain the growth of the market. Technological advancements such as robotics and integration of artificial intelligence (AI) in neurointerventional devices offer lucrative growth opportunity for the neurointerventional devices market.
The neurointerventional devices market is segmented on the basis of product, indication, end user, and region. By product type, the market is categorized into catheter, wires, stents, embolic coils, and others. The others include embolic protection device, and long sheath. By indication, the market is categorized into brain aneurysm, stroke, vascular malformations, and others. The others include vascular malformations, arteriovenous fistula, and arteriovenous malformation (AVM).
By end user, the market is categorized into hospitals and ambulatory surgical center. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). Major key players that operate in the global neurointerventional devices market are Stryker Corporation, Johnson & Johnson, Medtronic plc, Terumo Corporation, Lepu Medical Technology (Beijing) Co., Ltd, Merit Medical Systems Inc, Balt Group, Integer Holdings Corporation, Penumbra, Inc., and Cook Group Inc.
Key Benefits For Stakeholders
-This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the neurointerventional devices market analysis from 2022 to 2032 to identify the prevailing neurointerventional devices market opportunities.
-The market research is offered along with information related to key drivers, restraints, and opportunities.
-Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
-In-depth analysis of the neurointerventional devices market segmentation assists to determine the prevailing market opportunities.
-Major countries in each region are mapped according to their revenue contribution to the global market.
-Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
-The report includes the analysis of the regional as well as global neurointerventional devices market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
- Stents
- Embolic Coils
- Catheter
- Wires
- Others
By Indication
- Brain Aneurysm
- Stroke
- Others
By Application
- Hospitals
- Ambulatory Surgical Centers
- Others
By Region
- North America
? U.S.
? Canada
? Mexico
- Europe
? Germany
? France
? UK
? Italy
? Spain
? Rest of Europe
- Asia-Pacific
? Japan
? China
? Australia
? India
? South Korea
? Rest of Asia-Pacific
- LAMEA
? Brazil
? Saudi Arabia
? South Africa
? Rest of LAMEA
- Key Market Players
? Balt Group
? Cook Group Inc
? Integer Holdings Corporation
? Johnson & Johnson
? Lepu Medical Technology (Beijing) Co., Ltd
? Medtronic plc
? Merit Medical Systems Inc.
? Penumbra, Inc
? Stryker Corporation.
? Terumo Corporation

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter's five forces analysis
3.3.1. Low bargaining power of suppliers
3.3.2. Low threat of new entrants
3.3.3. Low threat of substitutes
3.3.4. Low intensity of rivalry
3.3.5. Low bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Surge in prevalence of neurological disorders
3.4.1.2. Rise in awareness about neurological disorders
3.4.1.3. Rise in demand for minimal invasive procedures

3.4.2. Restraints
3.4.2.1. High cost of neurointerventional devices

3.4.3. Opportunities
3.4.3.1. Technological advancement in neurointerventional devices

3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Stents
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Embolic Coils
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Catheter
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Wires
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
4.6. Others
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market share analysis by country
CHAPTER 5: NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Brain Aneurysm
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Stroke
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Others
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
CHAPTER 6: NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Ambulatory Surgical Centers
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: NEUROINTERVENTIONAL DEVICES MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Product
7.2.3. Market size and forecast, by Indication
7.2.4. Market size and forecast, by Application
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Product
7.2.5.1.3. Market size and forecast, by Indication
7.2.5.1.4. Market size and forecast, by Application
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Product
7.2.5.2.3. Market size and forecast, by Indication
7.2.5.2.4. Market size and forecast, by Application
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Product
7.2.5.3.3. Market size and forecast, by Indication
7.2.5.3.4. Market size and forecast, by Application
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Product
7.3.3. Market size and forecast, by Indication
7.3.4. Market size and forecast, by Application
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Product
7.3.5.1.3. Market size and forecast, by Indication
7.3.5.1.4. Market size and forecast, by Application
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Product
7.3.5.2.3. Market size and forecast, by Indication
7.3.5.2.4. Market size and forecast, by Application
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Product
7.3.5.3.3. Market size and forecast, by Indication
7.3.5.3.4. Market size and forecast, by Application
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Product
7.3.5.4.3. Market size and forecast, by Indication
7.3.5.4.4. Market size and forecast, by Application
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Product
7.3.5.5.3. Market size and forecast, by Indication
7.3.5.5.4. Market size and forecast, by Application
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Product
7.3.5.6.3. Market size and forecast, by Indication
7.3.5.6.4. Market size and forecast, by Application
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Product
7.4.3. Market size and forecast, by Indication
7.4.4. Market size and forecast, by Application
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Product
7.4.5.1.3. Market size and forecast, by Indication
7.4.5.1.4. Market size and forecast, by Application
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Product
7.4.5.2.3. Market size and forecast, by Indication
7.4.5.2.4. Market size and forecast, by Application
7.4.5.3. Australia
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Product
7.4.5.3.3. Market size and forecast, by Indication
7.4.5.3.4. Market size and forecast, by Application
7.4.5.4. India
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Product
7.4.5.4.3. Market size and forecast, by Indication
7.4.5.4.4. Market size and forecast, by Application
7.4.5.5. South Korea
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Product
7.4.5.5.3. Market size and forecast, by Indication
7.4.5.5.4. Market size and forecast, by Application
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Product
7.4.5.6.3. Market size and forecast, by Indication
7.4.5.6.4. Market size and forecast, by Application
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Product
7.5.3. Market size and forecast, by Indication
7.5.4. Market size and forecast, by Application
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Product
7.5.5.1.3. Market size and forecast, by Indication
7.5.5.1.4. Market size and forecast, by Application
7.5.5.2. Saudi Arabia
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Product
7.5.5.2.3. Market size and forecast, by Indication
7.5.5.2.4. Market size and forecast, by Application
7.5.5.3. South Africa
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Product
7.5.5.3.3. Market size and forecast, by Indication
7.5.5.3.4. Market size and forecast, by Application
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Product
7.5.5.4.3. Market size and forecast, by Indication
7.5.5.4.4. Market size and forecast, by Application
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Stryker Corporation.
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.1.7. Key strategic moves and developments
9.2. Johnson & Johnson
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. Medtronic plc
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.4. Terumo Corporation
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. Integer Holdings Corporation
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.5.7. Key strategic moves and developments
9.6. Lepu Medical Technology (Beijing) Co., Ltd
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.7. Balt Group
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.8. Merit Medical Systems Inc.
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.9. Cook Group Inc
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.10. Penumbra, Inc
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance

LIST OF TABLES
TABLE 01. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 02. NEUROINTERVENTIONAL DEVICES MARKET FOR STENTS, BY REGION, 2022-2032 ($MILLION)
TABLE 03. NEUROINTERVENTIONAL DEVICES MARKET FOR EMBOLIC COILS, BY REGION, 2022-2032 ($MILLION)
TABLE 04. NEUROINTERVENTIONAL DEVICES MARKET FOR CATHETER, BY REGION, 2022-2032 ($MILLION)
TABLE 05. NEUROINTERVENTIONAL DEVICES MARKET FOR WIRES, BY REGION, 2022-2032 ($MILLION)
TABLE 06. NEUROINTERVENTIONAL DEVICES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 07. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 08. NEUROINTERVENTIONAL DEVICES MARKET FOR BRAIN ANEURYSM, BY REGION, 2022-2032 ($MILLION)
TABLE 09. NEUROINTERVENTIONAL DEVICES MARKET FOR STROKE, BY REGION, 2022-2032 ($MILLION)
TABLE 10. NEUROINTERVENTIONAL DEVICES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 11. GLOBAL NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 12. NEUROINTERVENTIONAL DEVICES MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
TABLE 13. NEUROINTERVENTIONAL DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2022-2032 ($MILLION)
TABLE 14. NEUROINTERVENTIONAL DEVICES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 15. NEUROINTERVENTIONAL DEVICES MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 16. NORTH AMERICA NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 17. NORTH AMERICA NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 18. NORTH AMERICA NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 19. NORTH AMERICA NEUROINTERVENTIONAL DEVICES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 20. U.S. NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 21. U.S. NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 22. U.S. NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 23. CANADA NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 24. CANADA NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 25. CANADA NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 26. MEXICO NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 27. MEXICO NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 28. MEXICO NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 29. EUROPE NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 30. EUROPE NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 31. EUROPE NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 32. EUROPE NEUROINTERVENTIONAL DEVICES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 33. GERMANY NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 34. GERMANY NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 35. GERMANY NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 36. FRANCE NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 37. FRANCE NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 38. FRANCE NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 39. UK NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 40. UK NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 41. UK NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 42. ITALY NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 43. ITALY NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 44. ITALY NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 45. SPAIN NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 46. SPAIN NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 47. SPAIN NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 48. REST OF EUROPE NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 49. REST OF EUROPE NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 50. REST OF EUROPE NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 51. ASIA-PACIFIC NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 52. ASIA-PACIFIC NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 53. ASIA-PACIFIC NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 54. ASIA-PACIFIC NEUROINTERVENTIONAL DEVICES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 55. JAPAN NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 56. JAPAN NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 57. JAPAN NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 58. CHINA NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 59. CHINA NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 60. CHINA NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 61. AUSTRALIA NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 62. AUSTRALIA NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 63. AUSTRALIA NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 64. INDIA NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 65. INDIA NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 66. INDIA NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 67. SOUTH KOREA NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 68. SOUTH KOREA NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 69. SOUTH KOREA NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 73. LAMEA NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 74. LAMEA NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 75. LAMEA NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 76. LAMEA NEUROINTERVENTIONAL DEVICES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 77. BRAZIL NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 78. BRAZIL NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 79. BRAZIL NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 80. SAUDI ARABIA NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 81. SAUDI ARABIA NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 82. SAUDI ARABIA NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 83. SOUTH AFRICA NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 84. SOUTH AFRICA NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 85. SOUTH AFRICA NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 86. REST OF LAMEA NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
TABLE 87. REST OF LAMEA NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022-2032 ($MILLION)
TABLE 88. REST OF LAMEA NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 89. STRYKER CORPORATION.: KEY EXECUTIVES
TABLE 90. STRYKER CORPORATION.: COMPANY SNAPSHOT
TABLE 91. STRYKER CORPORATION.: PRODUCT SEGMENTS
TABLE 92. STRYKER CORPORATION.: PRODUCT PORTFOLIO
TABLE 93. STRYKER CORPORATION.: KEY STRATERGIES
TABLE 94. JOHNSON & JOHNSON: KEY EXECUTIVES
TABLE 95. JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 96. JOHNSON & JOHNSON: PRODUCT SEGMENTS
TABLE 97. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
TABLE 98. JOHNSON & JOHNSON: KEY STRATERGIES
TABLE 99. MEDTRONIC PLC: KEY EXECUTIVES
TABLE 100. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 101. MEDTRONIC PLC: PRODUCT SEGMENTS
TABLE 102. MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 103. TERUMO CORPORATION: KEY EXECUTIVES
TABLE 104. TERUMO CORPORATION: COMPANY SNAPSHOT
TABLE 105. TERUMO CORPORATION: PRODUCT SEGMENTS
TABLE 106. TERUMO CORPORATION: PRODUCT PORTFOLIO
TABLE 107. TERUMO CORPORATION: KEY STRATERGIES
TABLE 108. INTEGER HOLDINGS CORPORATION: KEY EXECUTIVES
TABLE 109. INTEGER HOLDINGS CORPORATION: COMPANY SNAPSHOT
TABLE 110. INTEGER HOLDINGS CORPORATION: PRODUCT SEGMENTS
TABLE 111. INTEGER HOLDINGS CORPORATION: PRODUCT PORTFOLIO
TABLE 112. INTEGER HOLDINGS CORPORATION: KEY STRATERGIES
TABLE 113. LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD: KEY EXECUTIVES
TABLE 114. LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD: COMPANY SNAPSHOT
TABLE 115. LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD: PRODUCT SEGMENTS
TABLE 116. LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD: SERVICE SEGMENTS
TABLE 117. LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD: PRODUCT PORTFOLIO
TABLE 118. BALT GROUP: KEY EXECUTIVES
TABLE 119. BALT GROUP: COMPANY SNAPSHOT
TABLE 120. BALT GROUP: PRODUCT SEGMENTS
TABLE 121. BALT GROUP: PRODUCT PORTFOLIO
TABLE 122. MERIT MEDICAL SYSTEMS INC.: KEY EXECUTIVES
TABLE 123. MERIT MEDICAL SYSTEMS INC.: COMPANY SNAPSHOT
TABLE 124. MERIT MEDICAL SYSTEMS INC.: PRODUCT SEGMENTS
TABLE 125. MERIT MEDICAL SYSTEMS INC.: PRODUCT PORTFOLIO
TABLE 126. COOK GROUP INC: KEY EXECUTIVES
TABLE 127. COOK GROUP INC: COMPANY SNAPSHOT
TABLE 128. COOK GROUP INC: PRODUCT SEGMENTS
TABLE 129. COOK GROUP INC: SERVICE SEGMENTS
TABLE 130. COOK GROUP INC: PRODUCT PORTFOLIO
TABLE 131. PENUMBRA, INC: KEY EXECUTIVES
TABLE 132. PENUMBRA, INC: COMPANY SNAPSHOT
TABLE 133. PENUMBRA, INC: PRODUCT SEGMENTS
TABLE 134. PENUMBRA, INC: PRODUCT PORTFOLIO

LIST OF FIGURES
FIGURE 01. NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032
FIGURE 03. TOP INVESTMENT POCKETS IN NEUROINTERVENTIONAL DEVICES MARKET (2023-2032)
FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 05. LOW THREAT OF NEW ENTRANTS
FIGURE 06. LOW THREAT OF SUBSTITUTES
FIGURE 07. LOW INTENSITY OF RIVALRY
FIGURE 08. LOW BARGAINING POWER OF BUYERS
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALNEUROINTERVENTIONAL DEVICES MARKET
FIGURE 09. NEUROINTERVENTIONAL DEVICES MARKET, BY PRODUCT, 2022(%)
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF NEUROINTERVENTIONAL DEVICES MARKET FOR STENTS, BY COUNTRY 2022 AND 2032(%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF NEUROINTERVENTIONAL DEVICES MARKET FOR EMBOLIC COILS, BY COUNTRY 2022 AND 2032(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF NEUROINTERVENTIONAL DEVICES MARKET FOR CATHETER, BY COUNTRY 2022 AND 2032(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF NEUROINTERVENTIONAL DEVICES MARKET FOR WIRES, BY COUNTRY 2022 AND 2032(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF NEUROINTERVENTIONAL DEVICES MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 15. NEUROINTERVENTIONAL DEVICES MARKET, BY INDICATION, 2022(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF NEUROINTERVENTIONAL DEVICES MARKET FOR BRAIN ANEURYSM, BY COUNTRY 2022 AND 2032(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF NEUROINTERVENTIONAL DEVICES MARKET FOR STROKE, BY COUNTRY 2022 AND 2032(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF NEUROINTERVENTIONAL DEVICES MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 19. NEUROINTERVENTIONAL DEVICES MARKET, BY APPLICATION, 2022(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF NEUROINTERVENTIONAL DEVICES MARKET FOR HOSPITALS, BY COUNTRY 2022 AND 2032(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF NEUROINTERVENTIONAL DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF NEUROINTERVENTIONAL DEVICES MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 23. NEUROINTERVENTIONAL DEVICES MARKET BY REGION, 2022
FIGURE 24. U.S. NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 25. CANADA NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 26. MEXICO NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 27. GERMANY NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 28. FRANCE NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 29. UK NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 30. ITALY NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 31. SPAIN NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 32. REST OF EUROPE NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 33. JAPAN NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 34. CHINA NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 35. AUSTRALIA NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 36. INDIA NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 37. SOUTH KOREA NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 38. REST OF ASIA-PACIFIC NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 39. BRAZIL NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 40. SAUDI ARABIA NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 41. SOUTH AFRICA NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 42. REST OF LAMEA NEUROINTERVENTIONAL DEVICES MARKET, 2022-2032 ($MILLION)
FIGURE 43. TOP WINNING STRATEGIES, BY YEAR
FIGURE 44. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 45. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 46. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 47. COMPETITIVE DASHBOARD
FIGURE 48. COMPETITIVE HEATMAP: NEUROINTERVENTIONAL DEVICES MARKET
FIGURE 49. TOP PLAYER POSITIONING, 2022
FIGURE 50. STRYKER CORPORATION.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 51. STRYKER CORPORATION.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 52. STRYKER CORPORATION.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 53. JOHNSON & JOHNSON: NET SALES, 2020-2022 ($MILLION)
FIGURE 54. JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 55. JOHNSON & JOHNSON: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 56. MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)
FIGURE 57. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 58. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 59. TERUMO CORPORATION: NET SALES, 2020-2022 ($MILLION)
FIGURE 60. TERUMO CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 61. TERUMO CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 62. INTEGER HOLDINGS CORPORATION: NET SALES, 2020-2022 ($MILLION)
FIGURE 63. INTEGER HOLDINGS CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 64. INTEGER HOLDINGS CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 65. LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 66. LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 67. MERIT MEDICAL SYSTEMS INC.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 68. MERIT MEDICAL SYSTEMS INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 69. MERIT MEDICAL SYSTEMS INC.: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 70. PENUMBRA, INC: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 71. PENUMBRA, INC: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 72. PENUMBRA, INC: REVENUE SHARE BY SEGMENT, 2022 (%)

  • Not Sure / Need Reassuring
    • Confirm Content

      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages

      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives

      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices

      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts

      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies

      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses

      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License

      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats

      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery

      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges

      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card

      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer

      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security

      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security

      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE
  • $3456.00 $3110.40
  • $5730.00 $5157.00
  • $9600.00 $8640.00
  • ADD TO BASKET
  • BUY NOW